Peer-Reviewed Study Demands Immediate Global Ban on Covid ‘Vaccines’ Over Brain Clot Surge

0
243

by Frank Bergman, Slay News:

The researchers behind a major new peer-reviewed study are calling for an immediate ban on Covid mRNA “vaccines” after linking the injection to surges in deadly blood clots.

The team of leading American researchers, led by independent researcher Claire Rogers, sought to investigate spikes in cases of cerebral thrombosis – a potentially fatal blood clot in the brain.

The peer-reviewed study, titled “COVID-19 Vaccines: A Risk Factor for Cerebral Thrombotic Syndromes,” was just published in the International Journal of Innovative Research in Medical Science.

TRUTH LIVES on at https://sgtreport.tv/

Rogers collaborated with renowned experts from The Wellness Company and The McCullough Foundation for the study.

Among the team was celebrated cardiologist Dr. Peter McCullough.

During the study, the researchers collected official U.S. government data from the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).

They also accessed data from the CDC’s Vaccine Adverse Event Reporting System (VAERS) database from January 1, 1990 to December 31, 2023.

CTE AEs (cerebral thromboembolism adverse events) after Covid mRNA injections were compared to those after influenza shots and after all other vaccines using proportional reporting ratio (PRR) analysis by time.

They found that brain clots (cerebral thromboembolism adverse events) are 112,000% more likely to occur after receiving a Covid mRNA “vaccine” than an influenza shot.

When comparing Covid shots to all other vaccines combined, the likelihood is 20,700% higher.

After Covid mRNA vaccination, there were 5,137 reported cases of cerebral thromboembolism in just 3 years (36 months).

For influenza vaccines over the past 34 years (408 months), there were only 52 reported cases.

The researchers concluded by calling for all Covi mRNA shots to be pulled from the market, globally.

Read More @ SlayNews.com